Aker BioMarine — Capital/Financing Update 2020

Jul 6, 2020

Admission document

Admission document

6 July 2020 – The attached admission document (the "Admission Document") has been prepared by Aker BioMarine AS (the "Company") solely for use in connection with the admission to trading of all issued shares of the Company (the "Shares") on Merkur Market.

Arctic Securities AS, DNB Markets, part of DNB Bank ASA, and Skandinaviska Enskilda Banken AB (publ), Oslo branch have acted as Merkur Market advisors and Advokatfirmaet Schjødt AS has acted as legal advisor to the Company in connection with the admission to trading of the Shares on Merkur Market.

For further queries, please contact:

Katrine Klaveness, Chief Financial Officer, Aker BioMarine AS, telephone: +47 99 15 89 15

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary health.